• Home
  • NEW DAY MEDICINE
  • 6(56)2023
  • 5 -6 (56) 2023 — Khoshimov U.U., Khamraeva G.Sh. — INFLUENCE OF INFUSION THERAPY ON HEMODYNAMICS IN SEVERE COVID-19

5 -6 (56) 2023 — Khoshimov U.U., Khamraeva G.Sh. — INFLUENCE OF INFUSION THERAPY ON HEMODYNAMICS IN SEVERE COVID-19

INFLUENCE OF INFUSION THERAPY ON HEMODYNAMICS IN SEVERE COVID-19

Khoshimov U.U., Republican Specialized Scientific Practical Medical Center of Neurosurgery

Khamraeva G.Sh. Center for the development of professional qualifications of medical workers Uzbekistan Tashkent

Resume

The selection of the solution for its execution, evidence of the viability of the solutions used, and the volume of the implantation treatment itself for COVID-19 is still the subject of discussion, and the evidence base for existing proposals for fluid treatment is exceptionally limited. The purpose of the study: to assess the impact of infusion-transfusion treatment on cardiac hemodynamics in patients with serious COVID-19 in intensive care units.

The research included 52 patients with a considerably serious course of COVID-19, hospitalized within the intensive care and resuscitation divisions of the Zangiota Specialized Clinic No. 2 for the treatment of patients with coronavirus disease. When conducting an echocardiographic study, the diastolic work of the cleared-out ventricle, right ventricle, and markers of pulmonary hypertension were assessed, and the impact of infusion-transfusion treatment on cardiac hemodynamics was assessed.

The control of cardiac hemodynamics against the foundation of convenient determination of the sort and dose of agents for infusion-transfusion treatment in severe COVID-19 will let successful energetic observing of the course of the infection and may be pivotal in anticipating an adverse result of the disease.

Keywords: COVID-19, echocardiography, infusion-transfusion therapy.

First page

28

Last page

35

For citation: Khoshimov U.U., Khamraeva G.Sh. – INFLUENCE OF INFUSION THERAPY ON HEMODYNAMICS IN SEVERE COVID-19 //New Day in Medicine 2023 6(56): 28-36 https://newdaymedicine.com/index.php/2023/06/09/l-89/

LIST OF REFERENCES:

  1. Aripov A.N., Kayumov U.K., Inoyatova F.Kh., Khidoyatova M.R. Role of lungs in the hemostasis system (review of literature). Russian Clinical Laboratory Diagnostics.  2021 66(7):411-416. DOI: http:dx.doi.org/10.51620/0869-2084-2021-66-7-411-416
  2. Bi X, Su Z, Yan H, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count. Platelets. 202031(5):674-679. doi: 10.1080/09537104.2020.1760230
  3. Golukhova E.Z., Slivneva I.V., Rybka M.M., Mamalyga M.L., Marapov D.I., Klyuchnikov I.V. et al. Right ventricular systolic dysfunction as a predictor of adverse outcome in patients with COVID-19. Kardiologiia. 2020 60(11):16-29. [Russian: Голухова Е.З., Сливнева И.В., Рыбка М.М., Мамалыга М.Л., Марапов Д.И., Ключников И.В. и др. Кардиология. 202060(11):16–29]
  4. Grasselli G, Tonetti T, Filippini C, Slutsky AS, Pesenti A, Ranieri VM. Pathophysiology of COVID-19-associated acute respiratory distress syndrome – Authors’ reply. Lancet Respir Med. 2021 9(1):5-6. doi: 10.1016/S2213-2600(20)30525-7
  5. Inciardi R.M., Lupi L., Zaccone G. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020 5:819-824.
  6. Interim guidelines for the management of patients infected with coronavirus infection COVID-19. Version 8. Tashkent. 2021 8:44.
  7. Jellinge M.E., Henriksen D.P., Hallas P., Brabrand M. Hypoalbuminemia is a strong predictor of 30-day all-causemortality in acutely admittedmedical patients: a prospective, observational, cohort study. PLoS One. 2014 9(8):105-983. DOI: 10.1371/journal.pone.0105983
  8. Khidoyatova. M.R., Khamraeva G.Sh. ELECTROCARDIOGRAPHIC FINDINGS IN COVID-19. Uzbek Medical Journal .2020 4:61-64
  9. Leiderman I.N., Lesteva N.A., Kasherininov I.Yu., Kuzmin A.S., Akhimov P.S., Barinova S.A., Kanshaov N.Z., Mazurok V.A. Predictive value of serum albumin and urinary nitrogen excretion in intensive care unit patients with novel coronavirus infection (COVID-19): a single-center prospective cohort study. Intensive care bulletin named after A.I. Saltanov. 2021 3:61-68. DOI: 10.21320/1818-474X-2021-3-61-68
  10. Malbrain M.L.N.G., Van Regenmortel N., Owczuk R. It is time to consider the four D’s of fluid management. Anaesthesiology Intensive Therapy, 2015 47:1-5.
  11. Michael Dandel. Pathophysiology of COVID-19-associated acute respiratory distress syndrome Published Online November 13, 2020 https:doi.org/10.1016/ S2213-2600(20)30507-5
  12. Minardi J, Marsh C, Sengupta P. Risk-Stratifying COVID-19 Patients the Right Way. JACC Cardiovascular Imaging. 2020 13(11):2300-2303. doi: 10.1016/j.jcmg.2020.05.012
  13. S. Shi, M. Qin, B. Shen, et al.Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China J Am Med Assoc (2020), 10.1001/jamacardio.2020.0950
  14. Singh R, Kashyap R, Hutton A, Sharma M, Surani S. A Review of Cardiac Complications in Coronavirus Disease 2019. Cureus. 2020 12(5):8034. DOI: 10.7759/cureus.8034
  15. Surviving Sepsis Campaign Guidelines on the Management of Adults with Coronavirus Disease 2019 (COVID-19). Society of Critical Care Medicine and European Society of Intensive Care Medicine 1/2021
  16. Vincent J.L., Dubois M.J., Navickis R.J., and Wilkes M.M. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003 237(3):319-34. DOI: 10.1097/01.SLA.0000055547.93484.87
  17. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 395(10229):1054-62. DOI: 10.1016/S0140-6736(20)30566-3

file

download